Biotech

All Articles

OS Therapies refiles $6M IPO to cash HER2 medication, preclinical ADCs

.OS Therapies will certainly specify on the NYSE American inventory exchange this morning through a ...

ALX's waning CD47 action price sends stock spiraling down

.ALX Oncology's stage 2 stomach cancer reaction rate has actually compromised. After viewing its CD4...

Ionis axes eye disease from intendeds of Roche-partnered possibility after data disappoint

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has disappointed desires, motiv...

Biogen's chief executive officer said no unsafe sell 2023. He prepares to become daring

.While Biogen's pharma peers are seeking for late-stage assets with little threat, chief executive o...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Bio has actually been actually a biotech in search of a pipeline after it junked its lead po...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored rights to a very early Alzheimer's disease plan to Denali Therapeutics...

Takeda faucets brand new mind people oncology service-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of considerable management hirings, firings and...

Vertex, hammered through AATD again, drops 2 resources on discard pile

.Tip's try to alleviate an unusual hereditary health condition has actually reached an additional se...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of personnel

.Vir Biotechnology's second-quarter earnings file wasn't short of major information. The firm welcom...

Galapagos pauses CAR-T tissue treatment hearing over Parkinsonism instance

.Galapagos has stopped briefly enrollment in a test of a BCMA-directed CAR-T cell treatment, pushing...